HHC
AGN

Hutchin Hill Capital’s Allergan plc AGN Stock Holding History

Hutchin Hill Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-60,000
Closed -$16.1M – 793
2016
Q1 		$16.1M Buy
+60,000
New +$17.2M 0.47% 46

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Hutchin Hill Capital's AGN Position: Q4 2017 in Review

Hutchin Hill Capital reduced its Allergan plc (AGN) stake by 96% in Q4 2017, selling an estimated $8.88M and leaving 2,000 shares worth $327K. The position accounts for 0.09% of the portfolio, ranked #252.

Hutchin Hill Capital first reported a position in AGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $67.9M in Q1 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Hutchin Hill Capital held 2,000 shares of Allergan plc worth $327K as of Q4 2017.
  • Hutchin Hill Capital sold 49,500 Allergan plc shares in Q4 2017, an estimated $8.88M.
  • Allergan plc made up 0.09% of Hutchin Hill Capital's portfolio in Q4 2017, its #252 holding.
  • Hutchin Hill Capital first reported a position in Allergan plc in Q2 2013 and has held it in 15 quarters since.
  • Hutchin Hill Capital's Allergan plc position peaked at $67.9M in Q1 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.